<p>, /PRNewswire/ --</p>
<p>原因：罗森律师事务所是一家全球投资者权益律师事务所，提醒在 2024 年 8 月 7 日至 2025 年 2 月 24 日期间（包括这两个日期）购买 Maravai Lifesciences Holdings, Inc.（纳斯达克代码：MRVI）证券的投资者注意 2025 年 5 月 5 日的重要首席原告截止日期。</p>
<p>那么，<strong>：</strong> 如果您在该期间购买了 Maravai 证券，您可能有权在不支付任何自付费用或成本的情况下，通过风险代理安排获得赔偿。</p>
<p>接下来该做什么：要加入 Maravai 集体诉讼，请访问 https://rosenlegal.com/submit-form/?case_id=36259 或拨打无障碍电话 866-767-3653 联系 Phillip Kim 律师，或发送电子邮件至 [email protected] 获取有关集体诉讼的信息。集体诉讼已经提起。如果您希望担任首席原告，必须在 2025 年 5 月 5 日之前向法院提出申请。首席原告是代表其他集体成员在诉讼中行事的代表方。</p>
<p>为什么选择罗森律师事务所：我们鼓励投资者选择在领导角色中有成功记录的合格律师事务所。通常，发布通知的律师事务所没有可比的经验、资源或任何有意义的同行认可。这些律师事务所中的许多实际上并不进行证券集体诉讼，而只是作为中介，转介客户或与实际进行案件诉讼的律师事务所合作。在选择律师时要明智。罗森律师事务所代表全球投资者，专注于证券集体诉讼和股东衍生诉讼。罗森律师事务所曾在当时获得针对一家中国公司的最大证券集体诉讼和解。2017 年，罗森律师事务所被 ISS 证券集体诉讼服务评为证券集体诉讼和解数量第一。自 2013 年以来，该事务所每年均排名前四，并为投资者追回了数亿美元。仅在 2019 年，该事务所就为投资者争取了超过 4.38 亿美元。2020 年，创始合伙人 Laurence Rosen 被 law360 评选为原告律师界的巨头。该事务所的许多律师已获得 Lawdragon 和 Super Lawyers 的认可。</p>
<p>案件详情：根据诉讼，在该期间，被告作出了虚假和/或误导性的陈述，和/或未能披露以下内容：（1）Maravai 在与收入确认相关的财务报告方面缺乏足够的内部控制；（2）因此，Maravai 在 2024 财年对某些交易的收入确认不准确；（3）其商誉被高估；（4）因此，被告对 Maravai 的业务、运营和前景的积极陈述在实质上具有误导性和/或缺乏合理依据。</p>
<p>要加入 Maravai 集体诉讼，请访问 https://rosenlegal.com/submit-form/?case_id=36259 或拨打无障碍电话 866-767-3653 联系 Phillip Kim 律师，或发送电子邮件至 [email protected] 获取有关集体诉讼的信息。集体诉讼已经提起。</p>
<p>尚未认证集体。直到集体被认证，您不会被律师代表，除非您聘请一位。您可以选择您自己的律师。您也可以选择保持缺席集体成员身份，此时不采取任何行动。投资者分享任何潜在未来赔偿的能力并不依赖于担任首席原告。</p>
<p>请关注我们的 LinkedIn 更新：https://www.linkedin.com/company/the-rosen-law-firm，Twitter：https://twitter.com/rosen_firm 或 Facebook：https://www.facebook.com/rosenlawfirm/。</p>
<p>律师广告。先前的结果并不保证类似的结果。</p>
<p>联系信息：</p>
<p>Laurence Rosen 律师。</p>
<p>Phillip Kim 律师。</p>
<p>罗森律师事务所，P.A.。</p>
<p>275 Madison Avenue, 40th Floor</p>
<p>纽约，NY 10016</p>
<p>电话：（212）686-1060</p>
<p>免费电话：（866）767-3653</p>
<p>传真：（212）202-3827</p>
<p>[email protected]</p>
<p>www.rosenlegal.com</p>
<p>来源：罗森律师事务所，P.A.。</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwMzMxJk5ld3NJdGVtSWQ9REM1Mzk5NCZUcmFuc21pc3Npb25fSWQ9MjAyNTAzMzExODQzUFJfTkVXU19VU1BSX19fX19EQzUzOTk0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwMzMxJk5ld3NJdGVtSWQ9REM1Mzk5NCZUcmFuc21pc3Npb25fSWQ9MjAyNTAzMzExODQzUFJfTkVXU19VU1BSX19fX19EQzUzOTk0"/></p>

MRVI

<p>罗森律师事务所提醒在 2024 年 8 月 7 日至 2025 年 2 月 24 日期间购买了 Maravai Lifesciences Holdings, Inc.（纳斯达克代码：MRVI）证券的投资者，集体诉讼的主要原告截止日期为 2025 年 5 月 5 日。该诉讼指控 Maravai 在其财务报告和收入确认方面做出了误导性陈述。投资者可以在没有前期费用的情况下加入集体诉讼。欲了解更多信息，请联系 Phillip Kim 律师，电话：866-767-3653 或通过电子邮件联系</p>

<p>, /PRNewswire/ --</p>
<div class="lb-trans"><p>, /PRNewswire/ --</p>
</div><p>Why: Rosen Law Firm, a global investor rights law firm, reminds of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025, both dates inclusive (the &#34;Class Period&#34;), of the important May 5, 2025 lead plaintiff deadline.</p>
<div class="lb-trans"><p>原因：罗森律师事务所是一家全球投资者权益律师事务所，提醒在 2024 年 8 月 7 日至 2025 年 2 月 24 日期间（包括这两个日期）购买 Maravai Lifesciences Holdings, Inc.（纳斯达克代码：MRVI）证券的投资者注意 2025 年 5 月 5 日的重要首席原告截止日期。</p>
</div><p>So what <strong>:</strong> If you purchased Maravai securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.</p>
<div class="lb-trans"><p>那么，<strong>：</strong> 如果您在该期间购买了 Maravai 证券，您可能有权在不支付任何自付费用或成本的情况下，通过风险代理安排获得赔偿。</p>
</div><p>What to do next: To join the Maravai class action, go to https://rosenlegal.com/submit-form/?case_id=36259 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 5, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.</p>
<div class="lb-trans"><p>接下来该做什么：要加入 Maravai 集体诉讼，请访问 https://rosenlegal.com/submit-form/?case_id=36259 或拨打无障碍电话 866-767-3653 联系 Phillip Kim 律师，或发送电子邮件至 [email protected] 获取有关集体诉讼的信息。集体诉讼已经提起。如果您希望担任首席原告，必须在 2025 年 5 月 5 日之前向法院提出申请。首席原告是代表其他集体成员在诉讼中行事的代表方。</p>
</div><p>Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.</p>
<div class="lb-trans"><p>为什么选择罗森律师事务所：我们鼓励投资者选择在领导角色中有成功记录的合格律师事务所。通常，发布通知的律师事务所没有可比的经验、资源或任何有意义的同行认可。这些律师事务所中的许多实际上并不进行证券集体诉讼，而只是作为中介，转介客户或与实际进行案件诉讼的律师事务所合作。在选择律师时要明智。罗森律师事务所代表全球投资者，专注于证券集体诉讼和股东衍生诉讼。罗森律师事务所曾在当时获得针对一家中国公司的最大证券集体诉讼和解。2017 年，罗森律师事务所被 ISS 证券集体诉讼服务评为证券集体诉讼和解数量第一。自 2013 年以来，该事务所每年均排名前四，并为投资者追回了数亿美元。仅在 2019 年，该事务所就为投资者争取了超过 4.38 亿美元。2020 年，创始合伙人 Laurence Rosen 被 law360 评选为原告律师界的巨头。该事务所的许多律师已获得 Lawdragon 和 Super Lawyers 的认可。</p>
</div><p>Details of the case: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Maravai lacked adequate internal controls over financial reporting related to revenue recognition; (2) as a result, Maravai inaccurately recognized revenue on certain transactions during fiscal 2024; (3) its goodwill was overstated; and (4) as a result of the foregoing, defendants' positive statements about Maravai's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.</p>
<div class="lb-trans"><p>案件详情：根据诉讼，在该期间，被告作出了虚假和/或误导性的陈述，和/或未能披露以下内容：（1）Maravai 在与收入确认相关的财务报告方面缺乏足够的内部控制；（2）因此，Maravai 在 2024 财年对某些交易的收入确认不准确；（3）其商誉被高估；（4）因此，被告对 Maravai 的业务、运营和前景的积极陈述在实质上具有误导性和/或缺乏合理依据。</p>
</div><p>To join the Maravai class action, go to https://rosenlegal.com/submit-form/?case_id=36259 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed.</p>
<div class="lb-trans"><p>要加入 Maravai 集体诉讼，请访问 https://rosenlegal.com/submit-form/?case_id=36259 或拨打无障碍电话 866-767-3653 联系 Phillip Kim 律师，或发送电子邮件至 [email protected] 获取有关集体诉讼的信息。集体诉讼已经提起。</p>
</div><p>No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.</p>
<div class="lb-trans"><p>尚未认证集体。直到集体被认证，您不会被律师代表，除非您聘请一位。您可以选择您自己的律师。您也可以选择保持缺席集体成员身份，此时不采取任何行动。投资者分享任何潜在未来赔偿的能力并不依赖于担任首席原告。</p>
</div><p>Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.</p>
<div class="lb-trans"><p>请关注我们的 LinkedIn 更新：https://www.linkedin.com/company/the-rosen-law-firm，Twitter：https://twitter.com/rosen_firm 或 Facebook：https://www.facebook.com/rosenlawfirm/。</p>
</div><p>Attorney Advertising. Prior results do not guarantee a similar outcome.</p>
<div class="lb-trans"><p>律师广告。先前的结果并不保证类似的结果。</p>
</div><p>Contact Information:</p>
<div class="lb-trans"><p>联系信息：</p>
</div><p>Laurence Rosen, Esq.</p>
<div class="lb-trans"><p>Laurence Rosen 律师。</p>
</div><p>Phillip Kim, Esq.</p>
<div class="lb-trans"><p>Phillip Kim 律师。</p>
</div><p>The Rosen Law Firm, P.A.</p>
<div class="lb-trans"><p>罗森律师事务所，P.A.。</p>
</div><p>275 Madison Avenue, 40th Floor</p>
<div class="lb-trans"><p>275 Madison Avenue, 40th Floor</p>
</div><p>New York, NY 10016</p>
<div class="lb-trans"><p>纽约，NY 10016</p>
</div><p>Tel: (212) 686-1060</p>
<div class="lb-trans"><p>电话：（212）686-1060</p>
</div><p>Toll Free: (866) 767-3653</p>
<div class="lb-trans"><p>免费电话：（866）767-3653</p>
</div><p>Fax: (212) 202-3827</p>
<div class="lb-trans"><p>传真：（212）202-3827</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>www.rosenlegal.com</p>
<div class="lb-trans"><p>www.rosenlegal.com</p>
</div><p>SOURCE THE ROSEN LAW FIRM, P. A.</p>
<div class="lb-trans"><p>来源：罗森律师事务所，P.A.。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwMzMxJk5ld3NJdGVtSWQ9REM1Mzk5NCZUcmFuc21pc3Npb25fSWQ9MjAyNTAzMzExODQzUFJfTkVXU19VU1BSX19fX19EQzUzOTk0" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DC53994&amp;Transmission_Id=202503311843PR_NEWS_USPR_____DC53994&amp;DateId=20250331"/></p>

MRVI 投资者有机会主导 Maravai Lifesciences Holdings, Inc.的证券欺诈诉讼